Kiniksa Pharmaceuticals Files 8-K on Operations
Ticker: KNSA · Form: 8-K · Filed: Jul 29, 2025 · CIK: 1730430
| Field | Detail |
|---|---|
| Company | Kiniksa Pharmaceuticals International, PLC (KNSA) |
| Form Type | 8-K |
| Filed Date | Jul 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financials, reporting
TL;DR
Kiniksa Pharma dropped an 8-K, expect an update on financials soon.
AI Summary
Kiniksa Pharmaceuticals International, plc filed an 8-K on July 29, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This 8-K filing signals that Kiniksa Pharmaceuticals is providing updated information regarding its financial performance and condition to the SEC and its investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting operational and financial information, without immediate news of significant events like mergers or major setbacks.
Key Players & Entities
- Kiniksa Pharmaceuticals International, plc (company) — Registrant
- July 29, 2025 (date) — Date of earliest event reported
- 23 Old Bond Street, Floor 3 London , W1S 4PZ England , United Kingdom (location) — Address of principal executive offices
FAQ
What specific financial results are being reported in this 8-K?
The provided text of the 8-K filing indicates it is for 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not include the specific financial figures within this excerpt.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on July 29, 2025.
What is the principal executive office address for Kiniksa Pharmaceuticals International, plc?
The principal executive office is located at 23 Old Bond Street, Floor 3, London, W1S 4PZ, England, United Kingdom.
What is the SEC file number for Kiniksa Pharmaceuticals International, plc?
The SEC file number for Kiniksa Pharmaceuticals International, plc is 001-730430.
What is the Standard Industrial Classification (SIC) code for Kiniksa Pharmaceuticals International, plc?
The Standard Industrial Classification code for Kiniksa Pharmaceuticals International, plc is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 29, 2025 regarding Kiniksa Pharmaceuticals International, plc (KNSA).